Intra-articular Injections for Management of Knee OsteoarthritisDavid Golding1, James Brock1, Bethan Whiting1, Paul YF Lee1,2*
- *Corresponding Author:
- Paul YF Lee
Welshbone, South Wales Orthopaedics Research Network
E-mail: [email protected]
Received date: February 11, 2017; Accepted date: May 10, 2017; Published date: May 20, 2017
Citation: Golding D, Brock J, Whiting B, Lee PYF (2017) Intra-articular Injections for Management of Knee Osteoarthritis. J Arthritis 6:242. doi: 10.4172/2167-7921.1000242
Copyright: © 2017 Golding D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Knee pain is an increasingly common presentation to general practitioners worldwide which is thought to be related to the obesity epidemic, an ageing population and increasingly sedentary lifestyles in more developed nations. Degenerative osteoarthritis (OA) accounts for the majority of presentations in older age groups and this has traditionally been treated with analgesia, lifestyle modifications and adjuncts such as physiotherapy, braces and insoles. All these therapies aim to delay the need of total knee replacement (TKR), which is often the end-point for severe knee OA. However, TKR is associated with poor levels of patient satisfaction, low functional outcomes and has recently been shown to have low levels of cost-effectiveness except in patients with severe disabling OA. Increasingly doctors are turning to intra-articular injections which can provide temporary pain relief such as corticosteroids, hyaluronic acid and platelet rich plasma. This article aims to review the current options for intraarticular injections, comment on their efficacy and suggest areas for future development.